Cargando…

The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysis

INTRODUCTION: Traditionally, estrogen receptor (ER)-positive breast cancer has been defined as tumors with ≥1% positive for ER. The updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines recommend that tumors with ER expression of 1%-10% should be classi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paakkola, N.-M., Karakatsanis, A., Mauri, D., Foukakis, T., Valachis, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531568/ https://www.ncbi.nlm.nih.gov/pubmed/34678571 http://dx.doi.org/10.1016/j.esmoop.2021.100289

Ejemplares similares

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis
por: Zhu, Yajing, et al.
Publicado: (2022)

Mammographic Density Changes over Time and Breast Cancer Risk: A Systematic Review and Meta-Analysis
por: Mokhtary, Arezo, et al.
Publicado: (2021)

Yield of Surveillance Imaging After Mastectomy With or Without Reconstruction for Patients With Prior Breast Cancer: A Systematic Review and Meta-analysis
por: Smith, Daniel, et al.
Publicado: (2022)

PD-1 protein and gene expression as prognostic factors in early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2020)

Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis
por: Pantiora, Eirini, et al.
Publicado: (2022)

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease
por: Zerdes, Ioannis, et al.
Publicado: (2020)

Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk
por: Sund, Maria, et al.
Publicado: (2023)

Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis
por: Tan, Weige, et al.
Publicado: (2016)

The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
por: Korzets, Yasmin, et al.
Publicado: (2021)

The Prognostic Value of Estrogen Receptor β Isoform With Correlation of Estrogen Receptor α Among Sudanese Breast Cancer Patients
por: Shalabi, Manar G, et al.
Publicado: (2021)

Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study
por: Schiza, Aglaia, et al.
Publicado: (2020)

Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
por: Li, Ning, et al.
Publicado: (2022)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
por: Milosevic, Jelena, et al.
Publicado: (2013)

Estrogen receptor status has no prognostic relevance in metaplastic breast carcinoma
por: Abada, Evi, et al.
Publicado: (2022)

Prognostic Impact of Progesterone Receptor Status in Chinese Estrogen Receptor Positive Invasive Breast Cancer Patients
por: Yao, Nan, et al.
Publicado: (2017)

Characteristics and Prognosis of Estrogen Receptor Low-Positive Breast Cancer
por: Kim, Min Chong, et al.
Publicado: (2022)

Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis
por: Nikyar, Normehr, et al.
Publicado: (2022)

Integrated multi‐omics profiling of high‐grade estrogen receptor‐positive, HER2‐negative breast cancer
por: Wang, Kang, et al.
Publicado: (2021)

Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
por: Reinert, Tomás, et al.
Publicado: (2022)

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
por: Rosin, Justus, et al.
Publicado: (2023)

Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer
por: Kang, Young-Joon, et al.
Publicado: (2019)

Estrogen receptors and breast cancer.
por: Nicholson, R I, et al.
Publicado: (1981)

Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
por: Jinna, Nikita D., et al.
Publicado: (2023)

Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis
por: Zhang, Duo, et al.
Publicado: (2022)

Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox
por: Yu, Ke‐Da, et al.
Publicado: (2021)

Immune landscape of breast tumors with low and intermediate estrogen receptor expression
por: Voorwerk, Leonie, et al.
Publicado: (2023)

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives
por: Malainou, Christina Panagiotis, et al.
Publicado: (2023)

Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer
por: Harrod, Alison, et al.
Publicado: (2022)

The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER
por: Rajc, Jasmina, et al.
Publicado: (2018)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
por: Nath, Aritro, et al.
Publicado: (2022)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
por: Mutai, Raz, et al.
Publicado: (2021)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Outcomes of Different Quality of Life Assessment Modalities After Breast Cancer Therapy: A Network Meta-analysis
por: Kastora, Stavroula Lila, et al.
Publicado: (2023)

Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
por: Sestak, Ivana, et al.
Publicado: (2013)

Molecular Features of Androgen-Receptor Low, Estrogen Receptor-Negative Breast Cancers in the Carolina Breast Cancer Study
por: Jinna, Nikita, et al.
Publicado: (2023)

Association between low estrogen receptor positive breast cancer and staining performance
por: Caruana, Dennis, et al.
Publicado: (2020)

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer
por: Björner, Sofie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2bu61tqrs5sfigchcffqdkt26u